$SPHS News Sophiris Bio's topsalysin fails to

$SPHS News

Sophiris Bio's topsalysin fails to demonstrate efficacy for BPH-associated urinary tract symptoms 8:33 a.m. Today - Seeking Alpha
Sophiris Bio - Upcoming Catalysts Present Very Attractive Upside 9:30 a.m. Nov. 24, 2014 - Seeking Alpha
3 Stocks Pushing The Drugs Industry Lower 3:32 p.m. Nov. 13, 2014 - TheStreet.com
10-Q: SOPHIRIS BIO INC. 4:47 p.m. Nov. 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
Strength Seen in Sophiris Bio (SPHS): Stock Soars 25% - Tale of the Tape 9:46 a.m. Nov. 5, 2014 - Zacks.com
3 Drugs Stocks Nudging The Industry Higher 5:50 p.m. Oct. 6, 2014 - TheStreet.com
10-Q: SOPHIRIS BIO INC. 3:39 p.m. May 13, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-K: SOPHIRIS BIO INC. 3:25 p.m. March 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Sophiris Bio: Recent Price Action Offers An Attractive Entry Point 10:42 a.m. Dec. 31, 2013 - Seeking Alpha
Sophiris Bio: Under The Radar Despite 100% Upside 12:38 p.m. Oct. 31, 2013 - Seeking Alpha
From The Land of What If - Smart Proteins and Debt Collectors 9:03 p.m. Sept. 28, 2013 - GuruFocus.com
Sleepy Sector Wakes Up - Billionaires Hold Biotechs in 52-week Low 12:52 p.m. Sept. 3, 2013 - GuruFocus.com

Sophiris Bio Reports Administrative Interim Analysis for the "PLUS-1" Phase 3 Trial of PRX302 for Benign Prostatic Hyperplasia 8:02 a.m. Today - BusinessWire - BZX
Sophiris Bio to Present at the 26th Annual Piper Jaffray Healthcare Conference 8:02 a.m. Nov. 25, 2014 - BusinessWire - BZX
Sophiris Bio Reports Third Quarter Financial Results 4:07 p.m. Nov. 12, 2014 - BusinessWire - BZX
Sophiris Bio to Present at the Stifel 2014 Healthcare Conference 4:05 p.m. Nov. 7, 2014 - BusinessWire - BZX
Sophiris Bio to Present at the 13th Annual BIO Investor Forum 7:01 a.m. Sept. 30, 2014 - BusinessWire - BZX
Sophiris Bio Reports Completion of Enrollment in the "PLUS-1" Phase 3 Trial of PRX302 for Benign Prostatic Hyperplasia 7:01 a.m. Sept. 2, 2014 - BusinessWire - BZX
Sophiris Bio Reports Second Quarter Financial Results and Key Operational and Financial Highlights 3:08 p.m. Aug. 7, 2014 - BusinessWire - BZX
Sophiris Bio to Present at the Jefferies 2014 Global Healthcare Conference 3:06 p.m. May 22, 2014 - BusinessWire - BZX
Sophiris Enters into Common Stock Purchase Agreement with Aspire Capital to Support Proof of Concept Study of PRX302 in Prostate Cancer 7:02 a.m. May 19, 2014 - BusinessWire - BZX
Sophiris Bio Reports First Quarter Financial Results 3:06 p.m. May 13, 2014 - BusinessWire - BZX
Sophiris Bio to Present at the 13th Annual Needham Healthcare Conference 3:06 p.m. March 25, 2014 - BusinessWire - BZX
Sophiris Adds Gerald T. Proehl to its Board of Directors 7:01 a.m. March 20, 2014 - BusinessWire - BZX
Sophiris Bio Reports Fourth Quarter and Full Year 2013 Financial Results and Key Operational Highlights 3:16 p.m. March 13, 2014 - BusinessWire - BZX
Sophiris Bio to Present at the Cowen and Company 34th Annual Health Care Conference 8:03 a.m. Feb. 26, 2014 - BusinessWire - BZX
Sophiris Bio to Present at the 2014 Leerink Global Healthcare Conference 4:40 p.m. Feb. 3, 2014 - BusinessWire - BZX
Sophiris Bio Reports Third Quarter Financial Results and Recent Key Operational Highlights 4:05 p.m. Nov. 12, 2013 - BusinessWire
Sophiris Bio Applies for Voluntary Delisting from TSX 4:05 p.m. Nov. 5, 2013 - BusinessWire
Sophiris Announces First Patients Dosed in the "PLUS-1" Phase 3 Trial of PRX302 for Benign Prostatic Hyperplasia 3:05 p.m. Oct. 28, 2013 - BusinessWire
RDInvesting Provides Investors with Free In-Depth Equity Reports on AVNR, SGNT, SPHS and WLK 7:51 a.m. Sept. 12, 2013 - ACCESSWIRE
Sophiris Bio to Present at the Stifel Healthcare Conference 4:00 p.m. Sept. 5, 2013 - PR Newswire